MedPath

to evaluate the efficacy of amphotericin B injection in trearment of cutaneous leishmaniasis.

Not Applicable
Conditions
Cutaneous Leishmaniasis.
Cutaneous Leishmaniasis
Registration Number
IRCT201105223862N7
Lead Sponsor
Research council of mashhad University of Medical Sciences.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Inclusion Criteria: diagnosis of Cl based on direct skin smear or biopsy, lesion number less than 4, hypersensitivity to Antimoniate, resistance to Antimoniate therapy, informed consent signing
Exclusion criteria: hypersensitivity to amphotricin

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
esion healing. Timepoint: weekly. Method of measurement: measuring the size of induration and ulcer by caliper.
Secondary Outcome Measures
NameTimeMethod
Side effect. Timepoint: weekly. Method of measurement: clinical evaluation.
© Copyright 2025. All Rights Reserved by MedPath